These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34014528)

  • 1. Rational Design of PDZ Domain Inhibitors: Discovery of Small Organic Compounds Targeting PDZ Domains.
    Hoffer L; Roche P; Morelli X
    Methods Mol Biol; 2021; 2256():277-289. PubMed ID: 34014528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule inhibitors of AF6 PDZ-mediated protein-protein interactions.
    Vargas C; Radziwill G; Krause G; Diehl A; Keller S; Kamdem N; Czekelius C; Kreuchwig A; Schmieder P; Doyle D; Moelling K; Hagen V; Schade M; Oschkinat H
    ChemMedChem; 2014 Jul; 9(7):1458-62. PubMed ID: 24668962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in silico analysis of the binding modes and binding affinities of small molecule modulators of PDZ-peptide interactions.
    Tiwari G; Mohanty D
    PLoS One; 2013; 8(8):e71340. PubMed ID: 23951139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding by PDZ domains.
    Chi CN; Bach A; Strømgaard K; Gianni S; Jemth P
    Biofactors; 2012; 38(5):338-48. PubMed ID: 22674855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptic protein-protein interaction motifs in the cytoplasmic domain of MHCI proteins.
    Frietze KK; Pappy AL; Melson JW; O'Driscoll EE; Tyler CM; Perlman DH; Boulanger LM
    BMC Immunol; 2016 Jul; 17(1):24. PubMed ID: 27435737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motif mediated protein-protein interactions as drug targets.
    Corbi-Verge C; Kim PM
    Cell Commun Signal; 2016 Mar; 14():8. PubMed ID: 26936767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based identification of CaMKIIα-interacting MUPP1 PDZ domains and rational design of peptide ligands to target such interaction in human fertilization.
    Zhang YL; Han ZF; Sun YP
    Amino Acids; 2016 Jun; 48(6):1509-21. PubMed ID: 26984442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDZ domain-mediated protein interactions: therapeutic targets in neurological disorders.
    Khan Z; Lafon M
    Curr Med Chem; 2014; 21(23):2632-41. PubMed ID: 24606518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small-molecule compounds targeting the dishevelled PDZ domain by virtual screening and binding studies.
    Choi J; Ma S; Kim HY; Yun JH; Heo JN; Lee W; Choi KY; No KT
    Bioorg Med Chem; 2016 Aug; 24(15):3259-66. PubMed ID: 27112452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PDZ domain-mediated interactions.
    Grillo-Bosch D; Choquet D; Sainlos M
    Drug Discov Today Technol; 2013 Dec; 10(4):e531-40. PubMed ID: 24451645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure function relations in PDZ-domain-containing proteins: Implications for protein networks in cellular signalling.
    Manjunath GP; Ramanujam PL; Galande S
    J Biosci; 2018 Mar; 43(1):155-171. PubMed ID: 29485124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Fragments Binding to the PDZ1-2 Domain of PSD-95.
    Zang J; Ye F; Solbak SMØ; Høj LJ; Zhang M; Bach A
    ChemMedChem; 2021 Mar; 16(6):949-954. PubMed ID: 33305877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of a Conserved Lys/Arg Residue for Ligand/PDZ Domain Interactions as Examined by Protein Semisynthesis.
    Pedersen SW; Moran GE; Sereikaitė V; Haugaard-Kedström LM; Strømgaard K
    Chembiochem; 2016 Oct; 17(20):1936-1944. PubMed ID: 27472651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrocycles as protein-protein interaction inhibitors.
    Dougherty PG; Qian Z; Pei D
    Biochem J; 2017 Mar; 474(7):1109-1125. PubMed ID: 28298556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of diverse internal binding specificities of PDZ domains by yeast two-hybrid screening of a special peptide library.
    Mu Y; Cai P; Hu S; Ma S; Gao Y
    PLoS One; 2014; 9(2):e88286. PubMed ID: 24505465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition.
    Liu X; Fuentes EJ
    Int Rev Cell Mol Biol; 2019; 343():129-218. PubMed ID: 30712672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Protein Communication to Drug Discovery.
    Persico M; Di Dato A; Orteca N; Fattorusso C; Novellino E; Andreoli M; Ferlini C
    Curr Top Med Chem; 2015; 15(20):2019-31. PubMed ID: 25986690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.
    Zinzalla G; Thurston DE
    Future Med Chem; 2009 Apr; 1(1):65-93. PubMed ID: 21426071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN-PDZ domain interactions: binding of PTEN to PDZ domains of PTPN13.
    Sotelo NS; Schepens JT; Valiente M; Hendriks WJ; Pulido R
    Methods; 2015 May; 77-78():147-56. PubMed ID: 25448478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.